1-8 of 8
harringtonines
Close
Sort by
Journal Articles

Casein Kinase 1 Delta Is a Novel Regulator of mRNA Translation and Druggable Target in Aggressive Lymphomas

Ipsita Pal, PhD, Sohani Das Sharma, PhD, Andre M. Grilo, PhD, Prabhjot S. Mundi, MD, Luigi Scotto, PhD, Abdullah Mahmood Ali, PhD, Luke E Berchowitz, PhD, Siddhartha Mukherjee, MD PhD, Owen O'Connor, MD PhD, Marko Jovanovic, PhD, Changchun Deng, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2864.
https://doi.org/10.1182/blood-2019-129528
Published: 2019
Journal Articles

The Hypomethylating Agent Decitabine Prior to Chemotherapy Improves the Therapy Efficacy in Refractory/Relapsed Acute Myeloid Leukemia Patients

Xuejie Jiang, Zhixiang Wang, Changxin Yin, Guopan Yu, Jieyu Ye, Yu Zhang, Zhiping Fan, Dan Xu, Xiaoli Liu, Ru Feng, Bing Xu, PhD, Jing Sun, MD, Qifa Liu, Bing Z Carter, Fanyi Meng
Journal: Blood
Blood (2015) 126 (23): 4932.
https://doi.org/10.1182/blood.V126.23.4932.4932
Published: 2015
Journal Articles

Three Novel Clonal Non-Characteristic Chromosome Aberrations in Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia

Hongxing Liu, MD, Wenjun Tian, MD, Fang Wang, MD, Juan Zhu, MD, Wen Teng, Hui Wang, MD, Tong Wang, MD, Ping Wu, MD, Ping Zhu, MD, Tong Wu, MD, Chunrong Tong, MD
Journal: Blood
Blood (2011) 118 (21): 4912.
https://doi.org/10.1182/blood.V118.21.4912.4912
Published: 2011
Journal Articles

Homo-Harringtonine (Omacetaxine mepesuccinate) Induces a Dramatic and Sustained Reduction of BCR-ABL T315I mutated Transcripts in Chronic Phase Chronic Myelogenous Leukemia Patients Resistant to Tyrosine Kinase Inhibitors.

Franck Nicolini, MD, PhD, Laurence Legros, MD, PhD, Lydia Roy, MD, PhD, Jean-Claude Chomel, MD, Kaddour Chabane, BSc, Sophie Ducastelle, MD, Selim Corm, MD, Mauricette Michallet, MD, PhD, Francois Guilhot, MD, Ali Turhan, MD, PhD, Sandrine Hayette, PhD
Journal: Blood
Blood (2008) 112 (11): 1103.
https://doi.org/10.1182/blood.V112.11.1103.1103
Published: 2008
Journal Articles

The Study of Bortezomib Alone or in Combination with Harringtonine or Arsenic Trioxide on Proliferation and Apoptosis of Multidrug Resistant Leukemic Cells.

Fan Yi Meng, Yan Xia Cai, Qi Xin Sun, Yun Bi Fu, Li Li
Journal: Blood
Blood (2007) 110 (11): 4193.
https://doi.org/10.1182/blood.V110.11.4193.4193
Published: 2007
Journal Articles

Effect of Valproic Acid on the Expression of P27 Kip1 and Multidrug Resistance in HL60 Cells.

Songmei Yin, MD, Danian Nie, MD, Shuangfeng Xie, MD, Yiqing Li, MD, Xiuju Wang, MD, Liping Ma, MD
Journal: Blood
Blood (2006) 108 (11): 4368.
https://doi.org/10.1182/blood.V108.11.4368.4368
Published: 2006
Journal Articles

Bortezomib Combined with Harringtonine or Arsenious Acid Induced Apoptosis in HL-60 Cells and Its Mechanism.

Fan Yi Meng, MD, Yun-bi Fu, MD, Qi-xin Sun, MD, Jun Xie, MD, Guang-biao Zhou, MD
Journal: Blood
Blood (2006) 108 (11): 4412.
https://doi.org/10.1182/blood.V108.11.4412.4412
Published: 2006
Journal Articles

Cocktail Therapy Increased the Survival Rate of APL.

Jin Zhou, PhD, Ran Meng, PhD, Limin Li, MD, Jie Yu, MD, Baofeng Yang, PhD
Journal: Blood
Blood (2005) 106 (11): 899.
https://doi.org/10.1182/blood.V106.11.899.899
Published: 2005